Retatrutide (RETA)

Pons

/

Create a token Launches PLP Analytics

Reading the launch

Launchpad

Create a token
Launches
PLP
Analytics
Profile

Resources

Docs
Support
Builders
Explorer
PONS token
Updates on X
GitHub

Legal

Terms of Use
Privacy Policy
MiCA Whitepaper
Takedown Requests
Law Enforcement Requests

Pons is a noncustodial software interface operated by Pons Labs, LLC. Pons does not hold your assets or keys, does not execute or reverse transactions, and is not a bank, broker, exchange, custodian, or investment adviser. Nothing on this site is financial, legal, or tax advice. Tokens are issued by their creators, not by Pons. They are highly volatile, may lose all value, and may have no liquidity. Listing or ranking a token is not an endorsement. You are responsible for your decisions, your wallet, and compliance with local law. Not available in restricted regions. Pons is not affiliated with Robinhood Markets, Inc.

Retatrutide (RETA) | Pons

Launches

RETA

by CoolChalkBeaver2mo agoLLY pair

Loading 6h candles

Curve0%00% of 8.73 LLY

Market cap: $5K
Holders: —
Trades: 14
Supply: 1B
Creator fee: 0%

Token: 0x923b44…14a85b
Curve: 0x11a63e…6666d6
Launched: Sep 2, 2026, 4:34 AM UTC

About

Retatrutide, Eli Lilly's newest weight-loss drug, helped people lose 30% of body weight, on par with weight-loss surgery

Reading trades.

Pay

LLY

You receive0 RETA

Slippage 1.0%

Equity pairs are not available in your region.